Our products

Haemostasis

Download the Summary of Product Characteristics (SPC) and Patient Information Leaflets (PILs) for our haemostasis products here:

 

NovoEight® - turoctocog alfa

PIP Code
NovoEight ® 250 IU
402-7744
PIL

NovoEight ® 500 IU 402-7751
PIL

NovoEight ® 1000 IU 402-7769
PIL

NovoEight ® 1500 IU 402-7777
PIL

NovoEight ® 2000 IU 402-7785
PIL

NovoEight ® 3000 IU 402-7793
PIL
 
   
Summary of Product Characteristics - Click here  
   
   

NovoSeven® - eptacog alfa (activated)

PIP Code

NovoSeven® 1mg

377-1672
PIL

NovoSeven® 2mg

377-1680
PIL

NovoSeven® 5mg

377-1698
PIL

NovoSeven® 8mg

377-1760
PIL

   
Summary of Product Characteristics - Click here
 
 
   
Refixia®    nonacog beta pegol PIP Code

Refixia®    500 IU 
 
408-2632
PIL
 

Refixia®    1000 IU
 
408-2616
PIL
 

Refixia®    2000 IU
 
408-2624
PIL
 
     
Summary of Product Characteristics - Click here    

 

 

 

  This medicine is subject to additional safety monitoring.  This will allow quick identification of new safety information.  You can help by reporting any side effects you may get.  See mhra.gov.uk/yellowcard for how to report side effects.

 

 

 

 

This page is intended for members of the UK public
UK20HRBD00001 Date of prep March 2020